Eun-Wie Cho
Overview
Explore the profile of Eun-Wie Cho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
268
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heo C, Lim W, Moon K, Yang J, Kim S, Kim H, et al.
Vaccines (Basel)
. 2024 Jun;
12(6).
PMID: 38932406
Approved COVID-19 vaccines primarily induce neutralizing antibodies targeting the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein. However, the emergence of variants of concern with RBD mutations poses challenges...
2.
Heo C, Lim W, Yang J, Son S, Kim S, Kim D, et al.
Front Immunol
. 2023 Dec;
14:1307693.
PMID: 38143750
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), had a major impact on both the global health and economy. Numerous virus-neutralizing antibodies...
3.
Yang J, Phan V, Heo C, Nguyen H, Lim W, Cho E, et al.
Sens Actuators B Chem
. 2023 Jan;
380:133331.
PMID: 36644652
Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has threatened public health globally, and the emergence of viral variants has exacerbated an already...
4.
Heo C, Lim W, Park I, Choi Y, Lim K, Cho E
Int J Oncol
. 2022 Nov;
61(6).
PMID: 36321789
Tumor‑associated (TA) autoantibodies are considered to be promising biomarkers for the early detection of cancer, prior to the development of clinical symptoms. In the present study, a novel TA autoantibody...
5.
Kim I, Lee J, Kim S, Heo C, Kim R, Cho E
Commun Biol
. 2021 Jun;
4(1):778.
PMID: 34163000
Cancer stem cells (CSCs) are regarded as essential targets to overcome tumor progression and therapeutic resistance; however, practical targeting approaches are limited. Here, we identify testis-specific Y-like protein 5 (TSPYL5)...
6.
Heo C, Hwang H, Lim W, Lee H, Yoo J, Lim K, et al.
Int J Mol Sci
. 2020 Dec;
21(24).
PMID: 33352757
Tumor-associated (TA) autoantibodies have been identified at the early tumor stage before developing clinical symptoms, which holds hope for early cancer diagnosis. We identified a TA autoantibody from HBx-transgenic (HBx-tg)...
7.
Choi S, Lee J, Kim R, Jung U, Kahm Y, Cho E, et al.
Int J Mol Sci
. 2020 Sep;
21(18).
PMID: 32971893
Studies have shown that cancer stem cells (CSCs) are involved in resistance and metastasis of cancer; thus, therapies targeting CSCs have been proposed. Here, we report that heat shock 70-kDa...
8.
Heo C, Hwang H, Lee H, Kwak S, Yoo J, Yu D, et al.
Sci Rep
. 2019 Aug;
9(1):11059.
PMID: 31363116
Tumor-associated autoantibodies are promising diagnostic biomarkers for early detection of tumors. We have screened a novel tumor-associated autoantibody in hepatocellular carcinoma (HCC) model mice. Its target antigen was identified as...
9.
Kim I, Lee J, Kim S, Hwang H, Kim T, Cho E
Cancer Sci
. 2018 Sep;
109(11):3519-3531.
PMID: 30191639
Microenvironment, such as hypoxia common to cancer, plays a critical role in the epithelial-to-mesenchymal transition (EMT) program, which is a major route of cancer metastasis and confers γ-radiation resistance to...
10.
Hwang H, Heo C, Lee H, Kwak S, Lim W, Yoo J, et al.
J Transl Med
. 2018 Jun;
16(1):177.
PMID: 29954402
Background: Tumor-associated (TA) autoantibodies, which are generated by the immune system upon the recognition of abnormal TA antigens, are promising biomarkers for the early detection of tumors. In order to...